AI CuratorAI-generated

Research summary · 9 d ago

AI summary · not yet reviewedSubjects not reportedNot reportedTrial registry record – peer review not applicable

Unknown Subjects in a Cross-Sectional Study on MS Lesions

In a study with 181 participants, the primary outcome was to assess the presence or absence of lesions on T2-weighted brain MRI, particularly for individuals at high and low risk for MS. The goal was to meet the 2010 MRI criteria for dissemination in space, but no results have been posted yet.

Tags: #MSResearch
Most relevant to: —
Source: Read original source

This plain-English summary was written by AI from a trial registry record and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Human efficacy: Not yet assessed
Mechanism: Not yet assessed
Evidence strength: Not yet assessed
Outcome: Not yet assessed

Why it matters

This study aims to understand how lesions relate to MS risk, which could enhance diagnostic criteria. However, the study design does not provide clinical trial results, casting doubt on its applicability.

What this does not prove

The study is not a clinical trial, so it does not report results for endpoints. Moreover, planned enrolment and endpoints are not findings.

Next milestone

No next milestone was established from the available source.

Study facts

Study design: Not reported
Participants / samples: 181 · basis not reported
Randomised: No
Controlled: Not reported
Primary endpoint met: Not reported
Relevant MS type: Not reported
Publication date: Not reported
Evidence reviewed: Trial registry record
Regulatory approval: Not reported
Research areas: Not classified

Original sources

Trial registrationRelating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility ↗

Supporting passages (7)

sample size"count": 181,

randomizedNo

primary endpoint"description": "For participants in the cross-sectional cohort, which consists of individuals at highest and lowest risk for MS, the primary outcome measure is the presence or absence of lesions on T2-weighted brain MRI that meet the 2010 MRI criteria for dissemination in space.",

primary endpointFor participants in the overall GEMS study, the primary outcome measure is the GERS itself, as most participants in this cohort will not undergo further testing.

findings"description": "For participants in the overall GEMS study, the primary outcome measure is the GERS itself, as most participants in this cohort will not undergo further testing.",

limitationsNo results are posted. Planned enrolment and endpoints are not findings.

limitations"description": "This is not a clinical trial"

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.